Heidi Overton faces Senate hearing on FDA nomination

Questions about this coverage

How did the left and right cover Heidi Overton faces Senate hearing on FDA nomination?

Of the 35 outlets on this story carrying a published leaning rating, 49% are rated left, 45% are rated centre, 6% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 39. The sections above set out what each side emphasised, in its own terms.

Is Heidi Overton faces Senate hearing on FDA nomination left or right?

Neither side dominates it. Of the 35 rated outlets on this story, 49% are rated left, 45% are rated centre, 6% are rated right, and no side holds the 70% this site would want before calling a field one-sided. A story is not left or right in any case; the outlets that carried it are what carry ratings.

Is the coverage of Heidi Overton faces Senate hearing on FDA nomination biased?

Heidi Overton faces Senate hearing on FDA nomination is one event reported by 39 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.

Which side is not reporting Heidi Overton faces Senate hearing on FDA nomination?

When we first saw this story, outlets rated right had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.

Which outlets covered Heidi Overton faces Senate hearing on FDA nomination?

39 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.

Who is Dr. Heidi Overton?

Dr. Heidi Overton is President Donald Trump's nominee to lead the Food and Drug Administration. Her confirmation hearing before the Senate is scheduled for Thursday.

What issues will senators likely question Dr. Overton on?

Senate lawmakers are expected to focus their questions on Dr. Overton's views regarding vaccines and the abortion pill mifepristone. Concerns about the FDA becoming too political have also been mentioned.

What specific claims have been made about Dr. Overton's past stances?

One report states Dr. Overton has called mifepristone 'dangerous to women'. Another indicates that as a White House aide, she worked to reduce the number of vaccines recommended for children.